Chordate Medical Holding

7.88

SEK

-23.5 %

Less than 1K followers

CMH

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview

Financials & Estimates

Ownership

-23.5%

-23.12%

-0.1%

-33.3%

-61.82%

-65.29%

-97.17%

-95.92%

-99.53%

Chordate Medical Holding is a medical technology company that has developed, patented and CE-marked Ozilia® Migraine, a neuromodulatory and drug-free treatment technique for chronic migraine and chronic rhinitis. The treatment has proven efficacy according to a clinical study and is marketed in selected markets in the EU and the Middle East. The company is headquartered in Kista.

Market cap

21.27M SEK

Turnover

218.57K SEK

Revenue

980K

EBIT %

-3,017.35 %

P/E

-

Dividend yield-%

-

Financial calendar

28.3

2025

Annual report '24

21.5

2025

General meeting '25

23.5

2025

Interim report Q1'25

ShowingAll content types

Regulatory press release3/4/2025, 4:40 PM

Chordate Medical Holding AB (publ) carries out a directed set-off issue to underwriters in the completed rights issue

Chordate Medical Holding

Press release2/20/2025, 2:17 PM

Chordate Medical Holding: BioStock: Chordate Medical's CEO on the rights issue outcome and way forward

Chordate Medical Holding

Regulatory press release2/19/2025, 8:35 AM

Chordate Medical announces the outcome of the rights issue

Chordate Medical Holding

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Press release2/13/2025, 9:30 AM

Final Push of the Subscription Period for Chordate Medical’s Rights Issue

Chordate Medical Holding

Press release2/6/2025, 8:39 AM

Chordate Medical: BioStock: Double celebration for Lipum

Chordate Medical Holding

Press release2/5/2025, 4:10 PM

Correction: Additional Major Shareholders Announce Full Subscription in Chordate Medical’s Ongoing Rights Issue

Chordate Medical Holding

Press release2/5/2025, 2:35 PM

Additional Major Shareholders Announce Full Subscription in Chordate Medical’s Ongoing Rights Issue

Chordate Medical Holding

Regulatory press release1/31/2025, 11:55 AM

Chordate Medical publishes information memorandum in connection with rights issue

Chordate Medical Holding

Regulatory press release1/28/2025, 5:10 PM

Bulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ)

Chordate Medical Holding

Press release1/14/2025, 10:36 AM

Chordate Medical: BioStock: Chordate's study results published in Neurology

Chordate Medical Holding

Press release1/13/2025, 7:30 AM

Groundbreaking Migraine Study on Ozilia Now Published in Prestigious Neurology Journal

Chordate Medical Holding

Press release1/10/2025, 7:30 AM

Chordate Expands Follow-Up Study PM010 with Key University Clinic in Switzerland

Chordate Medical Holding

Regulatory press release12/23/2024, 4:15 PM

Notice of extraordinary general meeting of Chordate Medical Holding AB (publ)

Chordate Medical Holding

Regulatory press release12/23/2024, 11:55 AM

Chordate decides on a preferential issue of units of approximately SEK 22.2 million consisting of ordinary shares and preference shares with a conditional share dividend upon sale of the business

Chordate Medical Holding

Press release12/16/2024, 8:05 AM

BioStock: Chordate Medical's CEO looks ahead to 2025 - "The exit process is our primary focus"

Chordate Medical Holding

Press release12/10/2024, 10:10 AM

Chordate Highlights the Role of 79 Granted Patents in Driving a Successful Exit Process

Chordate Medical Holding

Press release12/9/2024, 1:05 PM

Ozilia's Availability Across Chordate's Focus Markets

Chordate Medical Holding

Press release12/6/2024, 9:07 AM

Chordate Medical Obtains Trademark Registration for Ozilia® in Japan

Chordate Medical Holding

Regulatory press release11/20/2024, 12:15 PM

Chordate Medical Holding AB (publ) announces the outcome of warrants of series TO 8

Chordate Medical Holding

Regulatory press release11/14/2024, 7:30 AM

Last day of trading with warrants of series TO 8 in Chordate Medical Holding AB (publ)

Chordate Medical Holding

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.